TOP2A and breast carcinoma: In addition, the high expression of TOP2A can be shown in various relevant research reports to be closely related to poor prognosis of lung cancer, bladder urothelial carcinoma, breast cancer, adrenal cortical carcinoma [25, 44–46] and other cancers.